Device Trial Radar · NCT04799418
STEM-PD Open Label Extension (OLE)
Last checked: Nov 20, 2026Latest source record: Jul 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
148
Actual
Start
Sep 15, 2022
Primary completion
Feb 24, 2025
Study completion Feb 24, 2025
Sponsor
- Lead sponsor
- Scion NeuroStimNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 16, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study seeks to establish the safety and efficacy of extended twice daily time-varying caloric vestibular stimulation treatments for treating symptoms associated with Parkinson's disease. Only participants who completed the STEM-PD randomized controlled trial portion (NCT04797611) are eligible to participate in the open label extension portion.
Conditions
- Parkinson Disease
- Parkinson's Disease and Parkinsonism
Interventions
Open Label Extension StudyDevice
This study will investigate the safety and efficacy of extended treatments for the management of symptoms related to PD.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in The International Parkinson and Movement Disorder Society - Non-Motor Rating Scale (MDS-NMS) Total ScoreTime frame: 3 months (NCT04797611 RCT: Day 29 - Day 113; This OLE: Day 113 to Day 197)
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Movement Disorder Center of Arizona
Scottsdale, Arizona
14 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.